These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 57441)

  • 21. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients.
    Lamoureux G; Cosgrove J; Duquette P; Lapierre Y; Jolicoeur R; Vanderland F
    Clin Exp Immunol; 1981 Mar; 43(3):557-64. PubMed ID: 7026094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis: an overview.
    Rose AS
    Adv Neurol; 1981; 31():3-9. PubMed ID: 7325046
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfer factor as a therapy for multiple sclerosis: a follow-up study.
    Frith JA; McLeod JG; Basten A; Pollard JD; Hammond SR; Williams DB; Crossie PA
    Clin Exp Neurol; 1986; 22():149-54. PubMed ID: 3555898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New treatments for multiple sclerosis.
    Hallpike JF
    Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of patients with multiple sclerosis with transfer factor (author's transl)].
    Romano EL; Pulido M; Layrisse Z; Malavé I
    Acta Cient Venez; 1978; 29(1):49-52. PubMed ID: 757718
    [No Abstract]   [Full Text] [Related]  

  • 27. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes.
    Offner H; Raun NE; Konat G; Fog T; Clausen J
    Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF immunoglobulins G in multiple sclerosis.
    Caputo D; Zaffaroni M; Procaccia S
    Boll Ist Sieroter Milan; 1982; 61(5):393-403. PubMed ID: 6927183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunotherapy in infectious disease, autoimmunity and cancer.
    Spitler LE; Dau PC
    Acta Neurol Scand Suppl; 1977; 63():227-37. PubMed ID: 265668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selected methods of current treatment of multiple sclerosis].
    Orłowska E
    Neurol Neurochir Pol; 1980; 14(3):321-5. PubMed ID: 6158011
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment and management of multiple sclerosis.
    Liversedge LA
    Br Med Bull; 1977 Jan; 33(1):78-83. PubMed ID: 64272
    [No Abstract]   [Full Text] [Related]  

  • 34. Transfer factor is ineffective in amyotrophic lateral sclerosis.
    Olarte MR; Gersten JC; Zabriskie J; Rowland LP
    Ann Neurol; 1979 Apr; 5(4):385-8. PubMed ID: 443772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Transfer factor in multiple sclerosis.
    Behan PO
    Lancet; 1976 Jul; 2(7979):258. PubMed ID: 59273
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunological treatment in multiple sclerosis.
    Lancet; 1980 Nov; 2(8201):953-4. PubMed ID: 6107593
    [No Abstract]   [Full Text] [Related]  

  • 37. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic trial of immunosuppressive agents in multiple sclerosis.
    Neumann JW; Ziegler DK
    Neurology; 1972 Dec; 22(12):1268-71. PubMed ID: 4631348
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development].
    Cazzullo CL; Montanini R; Ghezzi A; Zaffaroni M; Giussani D; Loner R; Caputo D; Marforio S; Zibetti A
    Minerva Med; 1984 Nov; 75(43):2585-9. PubMed ID: 6392935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.